001     137741
005     20240604120452.0
024 7 _ |a 10.1242/bio.20149399
|2 doi
024 7 _ |a pmid:25063200
|2 pmid
024 7 _ |a pmc:PMC4133730
|2 pmc
024 7 _ |a altmetric:2538688
|2 altmetric
037 _ _ |a DZNE-2020-04063
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Toyoda, Yusuke
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Products of the Parkinson's disease-related glyoxalase DJ-1, D-lactate and glycolate, support mitochondrial membrane potential and neuronal survival.
260 _ _ |a Cambridge
|c 2014
|b Company
264 _ 1 |3 online
|2 Crossref
|b The Company of Biologists
|c 2014-07-25
264 _ 1 |3 print
|2 Crossref
|b The Company of Biologists
|c 2014-08-15
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1717424241_5454
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Parkinson's disease is associated with mitochondrial decline in dopaminergic neurons of the substantia nigra. One of the genes linked with the onset of Parkinson's disease, DJ-1/PARK7, belongs to a novel glyoxalase family and influences mitochondrial activity. It has been assumed that glyoxalases fulfill this task by detoxifying aggressive aldehyde by-products of metabolism. Here we show that supplying either D-lactate or glycolate, products of DJ-1, rescues the requirement for the enzyme in maintenance of mitochondrial potential. We further show that glycolic acid and D-lactic acid can elevate lowered mitochondrial membrane potential caused by silencing PINK-1, another Parkinson's related gene, as well as by paraquat, an environmental toxin known to be linked with Parkinson's disease. We propose that DJ-1 and consequently its products are components of a novel pathway that stabilizes mitochondria during cellular stress. We go on to show that survival of cultured mesencephalic dopaminergic neurons, defective in Parkinson's disease, is enhanced by glycolate and D-lactate. Because glycolic and D-lactic acids occur naturally, they are therefore a potential therapeutic route for treatment or prevention of Parkinson's disease.
536 _ _ |a 342 - Disease Mechanisms and Model Systems (POF3-342)
|0 G:(DE-HGF)POF3-342
|c POF3-342
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Erkut, Cihan
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Pan-Montojo, Francisco
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Boland, Sebastian
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Stewart, Martin P
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Müller, Daniel J
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Wurst, Wolfgang
|0 P:(DE-2719)2000028
|b 6
|u dzne
700 1 _ |a Hyman, Anthony A
|0 P:(DE-HGF)0
|b 7
|e Corresponding author
700 1 _ |a Kurzchalia, Teymuras V
|0 P:(DE-HGF)0
|b 8
773 1 8 |a 10.1242/bio.20149399
|b : The Company of Biologists, 2014-07-25
|n 8
|p 777-784
|3 journal-article
|2 Crossref
|t Biology Open
|v 3
|y 2014
|x 2046-6390
773 _ _ |a 10.1242/bio.20149399
|g Vol. 3, no. 8, p. 777 - 784
|0 PERI:(DE-600)2632264-X
|n 8
|q 3:8<777 - 784
|p 777-784
|t Biology open
|v 3
|y 2014
|x 2046-6390
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/137741/files/DZNE-2020-04063.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/137741/files/DZNE-2020-04063.pdf?subformat=pdfa
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133730
909 C O |o oai:pub.dzne.de:137741
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)2000028
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-342
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms and Model Systems
|x 0
914 1 _ |y 2014
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BIOL OPEN : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
920 1 _ |0 I:(DE-2719)1140001
|k AG Wurst
|l Genome Engineering
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1140001
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21